Digital Surgery Leader Caresyntax Extends Series C to Total Raise of $130 Million; BlackRock Funds and ProAssurance Join to Accelerate Growth

 Caresyntax, the leading enterprise-level digital surgery platform delivering actionable insights to make surgery smarter and safer, today announced a $30 million extension to its...

‘Game-changing’ ultrasound robot wins venture capital backing

After spending two years in stealth mode, Sydney-based medical device start-up Vexev has developed what it says is the world’s first tomographic ultrasound robot...

Eleos Health raises $8M for behavioral health focused AI voice tech

Former Secretary of the U.S. Department of Veterans Affairs Dr. David Shulkin is joining the company's board. This morning Eleos Health, a company that uses...

DTx Neuroglee raises $10 million to treat neurodegenerative diseases

The company is working with the Mayo Clinic on a tool called Neuroglee Connect. A Boston-based startup is looking to help treat neurodegenerative disease with...

AI-powered orthodontics startup InBrace lines up $102M for behind-the-teeth straightening tech

Venture capital megarounds have historically been few and far between in the orthodontic technology space, but if InBrace’s latest financing is any indication, investors...

Organ-on-a-chip maker Emulate secures $82M to expand scientific, commercial efforts

The organ-on-a-chip developer Emulate has raised $82 million to boost its offerings aimed at replicating human biology through easier-to-manage in vitro cellular models. Used in...

Alma gets $50M to boost therapists’ practices

Alma, a startup building tools to help therapists grow their practices and take insurance, raised $50 million in funding. It’s drummed up more than...

COVID test maker Cue Health takes aim at public debut with $100M IPO

After its portable, cartridge-based nasal swab test kit became the first at-home, nonprescription molecular diagnostic for COVID-19 to receive emergency use authorization from the...

Polymer tissue reconstruction firm raises €50m in financing round

TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, has closed a Series C round of financing, raising €50 million from...

Latest articles